Austin Mark John Insider Trades

Insider Trading History

Track insider trading activity for Austin Mark John. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Perspective Therapeutics
Perspective Therapeutics CATX
VP Finance/prin Fin&acct Offic
Holding Value $112k 34,500 shares
Last Trade
Jul 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$413k 34,500 shares
$11.96
$3.25
Perspective Therapeutics
Perspective Therapeutics CATX
VP Finance/prin Fin&acct Offic
Holding Value $273k 84,030 shares
Last Trade
Apr 23, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$51k 30,000 shares
$1.70
$3.25
Perspective Therapeutics
Perspective Therapeutics CATX
VP Finance/prin Fin&acct Offic
Holding Value $390k 120,000 shares
Last Trade
Apr 23, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$51k 30,000 shares
$1.70
$3.25
Perspective Therapeutics
Perspective Therapeutics ISR
VP Finance/prin Fin&acct Offic
Holding Value $297k 773,115 shares
Last Trade
Jun 12, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.4k 225,000 shares
$0.38
$0.38
Perspective Therapeutics
Perspective Therapeutics CATX
VP Finance/prin Fin&acct Offic
Holding Value $2.51M 773,115 shares
Last Trade
Jun 12, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$124k 225,000 shares
$0.55
$3.25
Perspective Therapeutics
Perspective Therapeutics CATX
VP Finance/prin Fin&acct Offic
Holding Value $1.78M 548,115 shares
Last Trade
Aug 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54k 150,000 shares
$0.36
$3.25
Perspective Therapeutics
Perspective Therapeutics ISR
VP Finance/prin Fin&acct Offic
Holding Value $210k 548,115 shares
Last Trade
Aug 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54k 150,000 shares
$0.36
$0.38
Perspective Therapeutics
Perspective Therapeutics CATX
VP Finance/prin Fin&acct Offic
Holding Value $176k 54,030 shares
Last Trade
Jun 09, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4k 13,800 shares
$0.29
$3.25
Perspective Therapeutics
Perspective Therapeutics ISR
VP Finance/prin Fin&acct Offic
Holding Value $15.4k 40,230 shares
Last Trade
Jun 08, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.45k 5,000 shares
$0.29
$0.38
Perspective Therapeutics
Perspective Therapeutics CATX
VP Finance/prin Fin&acct Offic
Holding Value $131k 40,230 shares
Last Trade
Jun 08, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.45k 5,000 shares
$0.29
$3.25
Perspective Therapeutics
Perspective Therapeutics ISR
Controller/prin Fin&acct Offic
Holding Value $153k 398,115 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$105k 133,500 shares
$0.79
$0.38
Perspective Therapeutics
Perspective Therapeutics ISR
Controller/prin Fin&acct Offic
Holding Value $102k 264,615 shares
Last Trade
Oct 22, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.1k 28,845 shares
$0.38
$0.38
Perspective Therapeutics
Perspective Therapeutics ISR
Controller/prin Fin&acct Offic
Holding Value $97.9k 255,000 shares
Last Trade
Jun 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.3k 30,000 shares
$0.61
$0.38
Perspective Therapeutics
Perspective Therapeutics ISR
Controller/prin Fin&acct Offic
Holding Value $86.4k 225,000 shares
Last Trade
Jun 18, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.5k 50,000 shares
$0.43
$0.38
Perspective Therapeutics
Perspective Therapeutics ISR
Controller/prin Fin&acct Offic
Holding Value $6.14k 16,000 shares
Last Trade
Nov 16, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.71k 4,283 shares
$0.40
$0.38
Perspective Therapeutics
Perspective Therapeutics ISR
Controller/prin Fin&acct Offic
Holding Value $4.5k 11,717 shares
Last Trade
Nov 13, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.01k 2,452 shares
$0.41
$0.38
Perspective Therapeutics
Perspective Therapeutics ISR
Controller/prin Fin&acct Offic
Holding Value $67.2k 175,000 shares
Last Trade
Jun 13, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46k 100,000 shares
$0.46
$0.38
Perspective Therapeutics
Perspective Therapeutics ISR
Controller/prin Fin&acct Offic
Holding Value $3.56k 9,265 shares
Last Trade
Nov 24, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1k 2,040 shares
$0.49
$0.38
Perspective Therapeutics
Perspective Therapeutics ISR
Controller/prin Fin&acct Offic
Holding Value $2.77k 7,225 shares
Last Trade
Nov 22, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$894 1,825 shares
$0.49
$0.38
Perspective Therapeutics
Perspective Therapeutics ISR
Controller/prin Fin&acct Offic
Holding Value $2.07k 5,400 shares
Last Trade
Nov 21, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.59k 5,400 shares
$0.48
$0.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up